about
Vaccination for hepatitis C virus: closing in on an evasive targetNitazoxanide for chronic hepatitis CNitazoxanide for chronic hepatitis C virus infectionRepurposing drugs for the treatment and control of helminth infectionsStructure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivoNiclosamide is a proton carrier and targets acidic endosomes with broad antiviral effectsBroad-spectrum agents for flaviviral infections: dengue, Zika and beyondProgress of small molecular inhibitors in the development of anti-influenza virus agents.Challenges of antibacterial discoveryNorovirus gastroenteritis successfully treated with nitazoxanideNitazoxanide : A Broad Spectrum AntimicrobialNitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model.HCV drug discovery aimed at viral eradication.Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia?Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide.Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication.Drug Delivery Strategies for Antivirals against Hepatitis B Virus.
P2860
Q22305922-D7668BE3-1A6E-4E7E-837A-5F5CD9DACACEQ24197485-26A6C42A-1E21-4680-9C02-CE3242171A5FQ24234215-25DF5D76-B38C-4837-B961-492775B6C8C7Q26823355-F46FD597-A009-4BC5-9D85-532F8A0DAB04Q28476470-0FF8E4DA-0588-4A78-94CB-C22BB791731EQ28484821-39BDBEEE-5236-4292-A0EB-7E6D6ED9078BQ29994527-EB564D7E-03BD-456E-A6E3-24E778F08FA0Q30234943-C5208E27-0F2E-4BC6-9FA3-47A25590A12BQ33793074-D09EB604-0450-4988-BD89-3DD012D80D75Q36012636-212524DA-07D8-421D-ACC7-ACAFF43A533AQ37037176-5805DA69-3CE2-4D2B-A7A9-CE89E1B7FA21Q37590577-5AEB0DD6-3540-47C1-87E1-B4000C79003AQ37664059-62405649-2912-4D79-A0DA-2FC50CB3B620Q37841768-C259BE74-0E58-48FF-BE92-8F6766629F41Q39518505-31A3FBC1-F656-4B4C-8A1F-295EA56EAF3EQ42430401-CC577057-76E0-4C02-92A5-5E01BB0E3A1CQ42740762-AB53560B-5032-41A5-9B24-6AEDC3834BB2Q54207883-F9CE9B3E-BF8C-4CAC-BF8C-68EA270F7548
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thiazolides: a new class of antiviral drugs.
@en
Thiazolides: a new class of antiviral drugs.
@nl
type
label
Thiazolides: a new class of antiviral drugs.
@en
Thiazolides: a new class of antiviral drugs.
@nl
prefLabel
Thiazolides: a new class of antiviral drugs.
@en
Thiazolides: a new class of antiviral drugs.
@nl
P2860
P1476
Thiazolides: a new class of antiviral drugs.
@en
P2093
Jean-François Rossignol
P2860
P304
P356
10.1517/17425250902988487
P407
P577
2009-06-01T00:00:00Z